Search research articles
Contact Us
Filters
Showing results (101-110 of 198) with videos related to
Page
of 20
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN
|
February 21, 2020
Carbamylated Lipoproteins and Progression of Diabetic Kidney Disease
Kathryn C B Tan, Ching-Lung Cheung, Alan C H Lee, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
July 30, 2019
Development and Validation of a Risk Score to Predict the First Hip Fracture in the Oldest Old: A Retrospective Cohort Study
Ming-Tuen Lam, Chor-Wing Sing, Gloria H Y Li, et al.
Diabetes/Metabolism Research and Reviews
|
November 1, 2018
Galectin-3 and risk of cardiovascular events and all-cause mortality in type 2 diabetes
Kathryn C B Tan, Ching-Lung Cheung, Alan C H Lee, et al.
Plos One
|
September 2, 2015
Serum Level of Soluble Receptor for Advanced Glycation End Products Is Associated with A Disintegrin And Metalloproteinase 10 in Type 1 Diabetes
Alan C H Lee, Joanne K Y Lam, Sammy W M Shiu, et al.
Plos One
|
September 3, 2014
Cellular cholesterol transport proteins in diabetic nephropathy
Joseph G S Tsun, Susan Yung, Mel K M Chau, et al.
Sleep
|
March 24, 2006
Advanced glycation endproducts in nondiabetic patients with obstructive sleep apnea
Kathryn C B Tan, Wing-Sun Chow, Jamie C M Lam, et al.
Diabetologia
|
February 9, 2018
Galectin-3 is independently associated with progression of nephropathy in type 2 diabetes mellitus
Kathryn C B Tan, Ching-Lung Cheung, Alan C H Lee, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 8, 2021
Association Between SGLT2 Inhibitors vs DPP-4 Inhibitors and Risk of Pneumonia Among Patients With Type 2 Diabetes
Philip C M Au, Kathryn C B Tan, Bernard M Y Cheung, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 18, 2022
Association Between SGLT2 Inhibitors vs DPP4 Inhibitors and Renal Outcomes Among Patients With Type 2 Diabetes
Philip C M Au, Kathryn C B Tan, Bernard M Y Cheung, et al.
Diabetes Care
|
July 29, 2003
C-reactive protein predicts the deterioration of glycemia in chinese subjects with impaired glucose tolerance
Kathryn C B Tan, Nelson M S Wat, Sidney C F Tam, et al.
Page
of 20
Search research articles
Search
Showing results (101-110 of 198) with videos related to
Sort By:
Page
of 20
Clinical Journal of the American Society of Nephrology : CJASN
|
February 21, 2020
Carbamylated Lipoproteins and Progression of Diabetic Kidney Disease
Kathryn C B Tan, Ching-Lung Cheung, Alan C H Lee, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
July 30, 2019
Development and Validation of a Risk Score to Predict the First Hip Fracture in the Oldest Old: A Retrospective Cohort Study
Ming-Tuen Lam, Chor-Wing Sing, Gloria H Y Li, et al.
Diabetes/Metabolism Research and Reviews
|
November 1, 2018
Galectin-3 and risk of cardiovascular events and all-cause mortality in type 2 diabetes
Kathryn C B Tan, Ching-Lung Cheung, Alan C H Lee, et al.
Plos One
|
September 2, 2015
Serum Level of Soluble Receptor for Advanced Glycation End Products Is Associated with A Disintegrin And Metalloproteinase 10 in Type 1 Diabetes
Alan C H Lee, Joanne K Y Lam, Sammy W M Shiu, et al.
Plos One
|
September 3, 2014
Cellular cholesterol transport proteins in diabetic nephropathy
Joseph G S Tsun, Susan Yung, Mel K M Chau, et al.
Sleep
|
March 24, 2006
Advanced glycation endproducts in nondiabetic patients with obstructive sleep apnea
Kathryn C B Tan, Wing-Sun Chow, Jamie C M Lam, et al.
Diabetologia
|
February 9, 2018
Galectin-3 is independently associated with progression of nephropathy in type 2 diabetes mellitus
Kathryn C B Tan, Ching-Lung Cheung, Alan C H Lee, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 8, 2021
Association Between SGLT2 Inhibitors vs DPP-4 Inhibitors and Risk of Pneumonia Among Patients With Type 2 Diabetes
Philip C M Au, Kathryn C B Tan, Bernard M Y Cheung, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 18, 2022
Association Between SGLT2 Inhibitors vs DPP4 Inhibitors and Renal Outcomes Among Patients With Type 2 Diabetes
Philip C M Au, Kathryn C B Tan, Bernard M Y Cheung, et al.
Diabetes Care
|
July 29, 2003
C-reactive protein predicts the deterioration of glycemia in chinese subjects with impaired glucose tolerance
Kathryn C B Tan, Nelson M S Wat, Sidney C F Tam, et al.
Page
of 20